Kyowa Hakko’s citicoline supplementation may slow glaucoma
18 Aug 2017 --- A 500mg dose of citicoline from Kyowa Hakko Europe (Kyowa) may significantly slow the progression of visual acuity loss due to glaucoma. This is according to a new study by researchers at the Sao Paolo Hospital Eye Clinic at the University of Milan, who followed 41 patients with progressing glaucoma – a disease that damages the optic nerve and can lead to vision problems and blindness – over two years. “We are always excited to see that additional scientific data has been established to support its further benefits for eye health,” Oksana Ritchie, the company’s European Marketing Manager, tells NutritionInsight. “We will review our marketing strategy going forward based on these additional findings.” Rate of progression drops dramatically Participants were given an oral solution that contained 500mg of citicoline from Kyowa. The results as were described as “astounding” by the company, as the mean rate of progression dropped dramatically compared to the two years prior to the study. The study also found that there was a statistically significant decrease in intraocular pressure. It is not conclusive that citicoline alone is responsible for the results; however, supplementation with citicoline may be beneficial in overall brain and eye health. “Kyowa, and also our customers in recent years, have continuously published new science to substantiate the efficacy of this ingredient in various applications,” Ritchie comments on the potential for future, larger-scale studies. “Preparations for different studies to be published over the next coming years are already on our roadmap.” Future possibilities When it comes to future possible applications, Ritchie says: “Our [research is] proactively working on extending the use of citicoline for a far wider variety of age groups and target applications, sports nutrition being a good example.” “Together with specialists in eye health and our customers [who believe] in citicoline benefits, we continue assessing the possibilities of future research and studies about citicoline efficacy for neuroprotection,” she adds. The study, “Citicoline Oral Solution in Glaucoma: Is There a Role in Slowing Disease Progression?” was published online in Ophthalmologica. A link to the abstract can be found here. To contact our editorial team please email us at editorial@cnsmedia.com
Kyowa Hakko Europe GmbH
Collapse
COMPANY DETAILSKyowa Hakko Europe GmbH Am Wehrhahn 50 40211 Düsseldorf Germany
Tel. +49 211 175 450 ACTIVE CATEGORIESAmino Acids, Chemicals - Acids and Salts, Nutraceutical and Functional Food Ingredients Kyowa Hakko Europe is offering a line of well-researched branded ingredients and an extensive portfolio of ultra-pure amino acids, vitamins, nucleic acids and related compounds for use in pharmaceutical, nutritional and industrial applications. Kyowa Hakko Europe together with its daughter company Kyowa Hakko Bio Italia represent the European Sales Force of KYOWA HAKKO BIO CO., LTD., a Japanese company with combined strengths in bio-technology and fermentation. With its innovative and patented fermentation process built over the years, which excludes the usage of any animal origin material, KYOWA has become a trusted pioneer in the healthcare field, making substantial contributions to the health and well-being of people around the world. Our core business areas: • Pharmaceuticals Pharmaceuticals Pharmaceutical companies around the world purchase our high-quality Active Pharmaceutical Ingredients (API’s) and excipients that can be used in a wide variety of pharmaceutical applications including: • APIs Supplement & Nutrition Kyowa is committed to producing pure products of the highest quality for life-enhancing benefits. Decades of research and refinement have gone into developing our standards and methods of purification. Our bulk product offerings: • Meet or exceed high purity standards Kyowa Quality®
Our ingredients are backed by the same standard of excellence that has come to be associated with the KYOWA name.
Our branded ingredients are exclusively manufactured by KYOWA HAKKO BIO CO., LTD., and have been designed and clinically tested to deliver targeted, condition-specific consumer health benefits.
A proprietary form of citicoline, Cognizin® is a potent brain nutrient that’s been clinically shown to support mental energy, focus, attention and recall. Tested in human clinical trials and developed using a patented fermentation process, Cognizin® has a Novel Food status in Europe. It is a pure, allergen-free ingredient that is stable and effective. More >> https://cognizin.com/
Kyowa’s branded form of glutathione, a master antioxidant, which protects cells against oxidative damage, detoxifies toxic substances and plays a role in the maintenance of immunological functions. Pure, vegetarian, GMP compliant and approved to be used in dietary supplements. Highly effective and clinically tested ingredient. More >> www.setriaglutathione.com
A highly effective and clinically tested ingredient for hydration, endurance and recovery. Its unique dipeptide structure helps fast, easy and effective delivery of two amino acids L-Alanine and L-Glutamine in the body. Sustamine® has GRAS and Novel Food status. It is vegetarian, tasteless, odorless and stable in liquids. More >> www.sustamine.com Related ArticlesHealth & Nutrition News Conveying overall wellness: Better-for-you NPD thrives on protein, fiber and natural platforms08 Nov 2018 --- With half of all food and beverage launches in 2018 year to date having a better-for-you claim, the surge in product innovation catering to consumer demands for a healthier lifestyle is clear-cut. But what are some of the standout strategies for creating products with a much sought after health halo? Yesterday’s webinar presented by Innova Market Insights cast a light on the role of protein, fiber and natural ingredients in providing formulators with key strategies to convey overall wellness in food and beverage development. Health & Nutrition News Study highlights heart-health boosting flavanols in cocoa31 Oct 2018 --- Healthy adults experienced improved blood vessel function and blood pressure, arterial stiffness and cholesterol after daily consumption of a cocoa extract enriched with flavanols and procyanidins. Published in the American Journal of Clinical Nutrition (AJCN) and funded by Mars Inc., the researchers note that this study undercovers the distinct processes behind the cardiovascular benefits of bioactive-rich cocoa, which can hopefully be generalized to the broader population with further exploration. Health & Nutrition News Pioneering treatment could end the need for insulin therapy in Type 2 Diabetes patients25 Oct 2018 --- Researchers at the Amsterdam UMC have come up with a novel method to ensure that diabetes Type 2 patients can avoid needing to undergo insulin therapy. Diabetes is a chronic disease characterized by an inability of the pancreas to produce enough insulin, a hormone that regulates blood sugar, or the body’s inability to effectively use the insulin it produces. According to the researchers, the new method could have myriad other benefits in reducing metabolic conditions. Health & Nutrition News How super? Nutrient dense profiles and innovative NPD drive superfruit growth12 Oct 2018 --- Despite there being no concise definition of a superfruit, this group of “health haloed” fruits are generally said to be rich in nutrients and offer dense health benefits, such as adaptogenic properties. As consumers are increasingly eager to seek out extra nutrition in every bite, superfruits of different kinds are popping up in a range of products and markets. Food Ingredients News Astaxanthin could help stave off sarcopenia in seniors10 Oct 2018 --- A formulation containing AstaReal natural astaxanthin can provide a 40 percent increase in endurance and significantly improves muscle function in sarcopenia sufferers. This is according to a study by AstaMed investigating muscle loss and functional decline in older adults with the disease. Sarcopenia affects nearly a quarter of adults older than 60. Researchers published the findings in The Journal of Cachexia, Sarcopenia and Muscle on the effectiveness of a new medical protocol to improve muscular function. More Articles |
.jpg)
Our ingredients bear the Kyowa Quality mark, which means that all KQ products are manufactured to meet highest quality assurance standards, supplying quality and trusted materials for various industries such as pharmaceuticals, foods, and cosmetics.
